Dissolution test as a surrogate for quality evaluation of rifampicin containing fixed dose combination formulationsAGRAWAL, Shrutidevi; PANCHAGNULA, Ramesh.International journal of pharmaceutics. 2004, Vol 287, Num 1-2, pp 97-112, issn 0378-5173, 16 p.Article

Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage formsAGRAWAL, Shrutidevi; PANCHAGNULA, Ramesh.Biopharmaceutics & drug disposition. 2005, Vol 26, Num 8, pp 321-334, issn 0142-2782, 14 p.Article

Biopharmaceutic and pharmacokinetic aspects of variable bioavailability of rifampicinPANCHAGNULA, Ramesh; AGRAWAL, Shrutidevi.International journal of pharmaceutics. 2004, Vol 271, Num 1-2, pp 1-4, issn 0378-5173, 4 p.Article

Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levelsAGRAWAL, Shrutidevi; SINGH, Inderjit; KANWAL JIT KAUR et al.International journal of pharmaceutics. 2004, Vol 276, Num 1-2, pp 41-49, issn 0378-5173, 9 p.Article

Assessment of bioequivalence of rifampicin, isoniazid and pyrazinamide in a four drug fixed dose combination with separate formulations at the same dose levelsAGRAWAL, Shrutidevi; KAUR, Kanwal Jit; SINGH, Inderjit et al.International journal of pharmaceutics. 2002, Vol 233, Num 1-2, pp 169-177, issn 0378-5173Article